| Affymax and Takeda to Present Hematide(TM)/peginesatide Phase 2 Data at the ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Hematide is an investigational agent for the treatment of anemia in chronic renal failure (also referred to as renal anemia). Affymax and investigators will ... read more |